Liposomal doxorubicin in first line metastatic HER-2-positive breast cancer for prevention the cardiotoxicity Journal title: OncoReview Authors: Ewa Chmielowska Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems